000			02344 a2200577 4500
005			20250517110132.0
264		0	_c20171121
008			201711s 0 0 eng d
022			_a1556-1380
024	7		_a10.1016/j.jtho.2016.07.013 _2doi
040			_aNLM _beng _cNLM
100	1		_aNovello, Silvia
245	0	0	_aAn Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer. _h[electronic resource]
260			_bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _c02 2017
300			_a383-389 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aCarcinoma, Large Cell _xdrug therapy
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPemetrexed _xadministration & dosage
650	0	4	_aPrognosis
650	0	4	_aSurvival Rate
700	1		_aScagliotti, Giorgio
700	1		_ade Castro, Gilberto
700	1		_aKiyik, Murat
700	1		_aKowalyszyn, Rubén
700	1		_aDeppermann, Karl-Matthias
700	1		_aArriola, Edurne
700	1		_aBosquee, Lionel
700	1		_aNovosiadly, Ruslan D
700	1		_aNguyen, Tuan S
700	1		_aForest, Amelie
700	1		_aTang, Shande
700	1		_aKambhampati, Siva Rama Prasad
700	1		_aCosaert, Jan
700	1		_aReck, Martin
773	0		_tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _gvol. 12 _gno. 2 _gp. 383-389
856	4	0	_uhttps://doi.org/10.1016/j.jtho.2016.07.013 _zAvailable from publisher's website
999			_c26272195 _d26272195